Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TRIM73 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
mRNA | TOR2A | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
mRNA | ASUN | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |
mRNA | CRYBA2 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
mRNA | RP13-512J5.1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |
mRNA | FBXW7 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
mRNA | OPRK1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
mRNA | ATP6V0A2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
mRNA | TMC8 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
mRNA | UCP3 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |